Myopain Seminars LLC is categorized under Family Practice Doctors in Bethesda, MD and active since 2009.
Myopain Seminars LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Jan Dommerholt at the company’s single location by writing to 7830 Old Georgetown Road, Bethesda, Maryland MD 20814 or by phoning (855) 209-1832. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Myopain Seminars LLC |
| Contact Person: | Jan Dommerholt |
| Address: | 7830 Old Georgetown Road, Bethesda, Maryland 20814 |
| Phone Number: | (855) 209-1832 |
| Website Address: | myopainseminars.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Myopain Seminars LLC was started in 2009 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jan Dommerholt for inquiries that concern Myopain Seminars LLC by calling the company number (855) 209-1832, as your correspondence is most welcome. Additionally, the physical location of the single location of Myopain Seminars LLC can be found at the coordinates 38.988032,-77.09999 as well as the street address 7830 Old Georgetown Road in Bethesda, Maryland 20814.
For its online presence, you may visit Myopain Seminars LLC’s website at myopainseminars.com and engage with its social media outlets through on Twitter and on Facebook.